Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 2023 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more...
View all videos

ASCO 2023

02–06 June 2023 | Chicago, IL

#ESMO26 | Xing Zhang shares results from a Phase II study of nab-paclitaxel + pegylated liposomal doxorubicin in advanced or unresectable malignant vascular tumors, including #angiosarcoma 💉📈

The combination achieved an ORR of around 50% and a PFS of around 8 months, and

It was lovely to speak with Yeon Hee Park at #ESMO26 to discuss strategic treatment sequencing in HR+ metastatic #BreastCancer 🧬🎯

She explores how disease-free interval, prior treatment, biomarkers and the choice of endocrine backbone and CDK4/6 inhibitor in the first line can

What’s next in HER2-mutant #NSCLC? 🧬

This #lungcancer awareness month, Joshua Sabari explores emerging combination strategies, balancing efficacy with toxicity and patient-reported outcomes, and the potential of brain-penetrant TKIs such as NVL-330.

▶️ Watch the interview:

Want to gain insight into the role of total neoadjuvant therapy in locally advanced #RectalCancer? 🩺💪

Check out our recent interview with Sara Lonardi (@sara_lonardi1) from #ESSO45, where she explains how delivering #chemotherapy and #radiotherapy before surgery offers a more

At #ESMO26, Ariane Steindl shares findings from a study of around 150 patients with progressive #BrainMetastases, in which those who received #radiotherapy before progression had lower TIL infiltration and higher levels of the immunosuppressive marker FOXP3 🧠☢️

Watch:

ASCO 2023

02–06 June 2023 | Chicago, IL
The 2023 ASCO Annual Meeting will be a unique and unparalleled opportunity to connect with one of the largest, most diverse audiences in global cancer care, highlighting the latest innovations in cancer research and education. We're excited to bring you the latest updates in oncology live from Chicago, IL. Stay tuned for expert interviews, podcasts, roundtable discussions, and more...
View all videos

#ESMO26 | Xing Zhang shares results from a Phase II study of nab-paclitaxel + pegylated liposomal doxorubicin in advanced or unresectable malignant vascular tumors, including #angiosarcoma 💉📈

The combination achieved an ORR of around 50% and a PFS of around 8 months, and

It was lovely to speak with Yeon Hee Park at #ESMO26 to discuss strategic treatment sequencing in HR+ metastatic #BreastCancer 🧬🎯

She explores how disease-free interval, prior treatment, biomarkers and the choice of endocrine backbone and CDK4/6 inhibitor in the first line can

What’s next in HER2-mutant #NSCLC? 🧬

This #lungcancer awareness month, Joshua Sabari explores emerging combination strategies, balancing efficacy with toxicity and patient-reported outcomes, and the potential of brain-penetrant TKIs such as NVL-330.

▶️ Watch the interview:

Want to gain insight into the role of total neoadjuvant therapy in locally advanced #RectalCancer? 🩺💪

Check out our recent interview with Sara Lonardi (@sara_lonardi1) from #ESSO45, where she explains how delivering #chemotherapy and #radiotherapy before surgery offers a more

At #ESMO26, Ariane Steindl shares findings from a study of around 150 patients with progressive #BrainMetastases, in which those who received #radiotherapy before progression had lower TIL infiltration and higher levels of the immunosuppressive marker FOXP3 🧠☢️

Watch:

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.